Wnt2 as a new therapeutic target in malignant pleural mesothelioma

被引：0
|
作者：
Xu, Z
Mazieres, J
He, B
You, L
Jablons, D
机构：
[1] Univ Calif San Francisco, Canc Ctr, San Francisco, CA 94143 USA
[2] INSERM, U563, Dept Innovat Therapeut & Oncol Mol, F-31052 Toulouse, France
[3] Univ Calif San Francisco, Canc Ctr, San Francisco, CA 94115 USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [31] MicroRNAs regulating wnt signaling are downregulated in malignant pleural mesothelioma
    Gee, Gretchen V.
    Koestler, Devin C.
    Christensen, Brock C.
    Sugarbaker, David J.
    Ugolini, Donatella
    Ivaldi, Giovanni P.
    Resnick, Murray B.
    Houseman, E. Andreas
    Kelsey, Karl T.
    Marsit, Carmen J.
    CANCER RESEARCH, 2010, 70
  • [32] Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
    Borea, Federica
    Franczak, Marika A.
    Garcia, Maria
    Perrino, Matteo
    Cordua, Nadia
    Smolenski, Ryszard T.
    Peters, Godefridus J.
    Dziadziuszko, Rafal
    Santoro, Armando
    Zucali, Paolo A.
    Giovannetti, Elisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [33] DKK1 stabilization as a new malignant pleural mesothelioma therapeutic avenue
    Guazzelli, A.
    Bakker, E.
    Sotgia, F.
    Listanti, M.
    Krstic-Demonacos, M.
    Mutti, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Zucali, Paolo Andrea
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 853 - 858
  • [35] An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
    Davis, Alexander
    Ke, Helen
    Kao, Steven
    Pavlakis, Nick
    LUNG CANCER-TARGETS AND THERAPY, 2022, 13 : 1 - 12
  • [36] The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
    Oguh-Olayinka, Lily
    Agarwal, Vijay
    Ranatunge, Dulani
    Campbell, Anne
    Laufer, Stefan
    Cawkwell, Lynn
    Lind, Michael J.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 985 - 995
  • [37] Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma
    Yang, Yi-Wei
    Marrufo, Angelica
    Chase, Jillian
    Woodard, Gavitt A.
    Jablons, David M.
    Lemjabbar-Alaoui, Hassan
    EXPERIMENTAL LUNG RESEARCH, 2021, 47 (01) : 9 - 25
  • [38] The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Marjorie G. Zauderer
    Nature Communications, 12
  • [39] The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Zauderer, Marjorie G.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [40] The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma
    Elshazley, Momen
    Sato, Mitsuo
    Hase, Tetsunari
    Yamashita, Ryo
    Yoshida, Kenya
    Toyokuni, Shinya
    Ishiguro, Futoshi
    Osada, Hirotaka
    Sekido, Yoshitaka
    Yokoi, Kohei
    Usami, Noriyasu
    Shames, David S.
    Kondo, Masashi
    Gazdar, Adi F.
    Minna, John D.
    Hasegawa, Yoshinori
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) : 2820 - 2831
12345